Depressive symptoms associated with dabigatran: a case report

Eryilmaz G., Enez Darcin A., DAĞOĞLU SAKİN R. N., Gogcegoz Gul I.

PSYCHOGERIATRICS, vol.15, no.3, pp.209-211, 2015 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1111/psyg.12099
  • Journal Name: PSYCHOGERIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.209-211
  • Keywords: antidepressants, dabigatran, depression, drug interaction, BRAIN, GENE
  • Istanbul University Affiliated: Yes

Abstract

Several studies have reported that depression and anxiety are very common in atrial fibrillation due to impaired quality of life. Dabigatran is an anti-aggregation agent used for the treatment of atrial fibrillation. In terms of drug interactions during treatment with dabigatran, patients suffering from minor depression are reported to be a population at risk. This report is about a 68-year-old man whose depressive symptoms were aggravated after taking dabigatran for atrial fibrillation. The case is discussed in terms of his aggravated depressive symptoms and the interaction between his prescription medications.